Immediate Effect Of Whole-Body Vibration And Walk in Osteoporosis/Osteopenia

Osteoporosis Clinical Trial

Official title:

Immediate Effect Of Whole-Body Vibration And Walk Over Muscle Strength, Balance And Functional Performance In Elderly People With Osteoporosis And Osteopenia: Clinical Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03448276
• Other study ID #: Vibration, Walk And Osteop
• Secondary ID: CAAE N. 80679117
• Status: Completed
• Phase: N/A
• Start date: February 26, 2018
• Est. completion date: August 8, 2019

Study information

• Verified date: October 2019
• Source: Universidade Federal de Pernambuco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Introduction: Osteoporosis and Osteopenia are common bone disorders, characterized by low bone mass, signs of bone deterioration and are responsible for typical bone fragility. Physical activity is certainly a valid prevention tool because it contributes to a healthy energy balance, increasing muscle mass and providing beneficial effects in bone metabolism. Stress induced by more vigorous activities such as weight lifting, increases the risk of injury, particularly in the elderly. Therefore, alternative strategies with lower risk of injury are indicated such as whole body vibration and walk.

Objective: Compare the effect whole body vibration and walking on muscular strength, balance and functional performance in the elderly with Osteoporosis and Osteopenia

Methods: It is a clinical trial study, controlled, parallel, randomized and blind, which will follow the guidelines established in the Consolidated Standards of Reporting Trials (CONSORT). Participants will be randomly distributed in 2 groups: the experimental group (GI) that will hold the training in the vibrating platform and the control group (GC) that will perform the walk, settling 1 treatment session. All participants will be subjected to the initial and final assessment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: August 8, 2019
• Est. primary completion date: January 9, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years to 90 Years

Eligibility

Inclusion Criteria:

• Confirmed diagnosis of osteoporosis or osteopenia examination of bone densitometry;

• Patients without severe neurological disease, vascular disorders, labyrinthitis and blindness;

• No use of gait auxiliaries;

• No history of fractures of the lower limbs in the last year;

• Do not be an alcoholic inactive (0 to 5 points) or less active (6 to 11 points) accordance with the usual physical activity questionnaire (QAFH).

Exclusion Criteria:

-Patients who submit to hypertensive peak, nausea and dizziness during the training program.

Related Conditions & MeSH terms

• Bone Diseases, Metabolic
• Osteoporosis

Intervention

Other:
• Training in the vibrating platform
20-minute workout will be held, which will include: heating (5 minutes and stretching for the muscles quadriceps and sural triceps), 10 and 5 min of cooling.
• Walk
Will be held 30 minutes of training, which will include the heating (5 minutes of stretching for the muscles quadriceps and sural triceps), 10 and 5 min of cooling.

Locations

Country	Name	City	State
Brazil	UFPE	Recife	Pernambuco

Sponsors (1)

Lead Sponsor	Collaborator
Universidade Federal de Pernambuco

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscular strength	Test of 1 repetition maximum (1RM)	20 minutes
Primary	Balance	Berg Balance scale (BBS). Minimum score 0 and maximum 56, the lower the score the greater the risk of falls.	20 minutes
Primary	Functional performance	Timed Up and Go test (TUG)	20 minutes
Primary	Balance	Stabilometry by Baropodometry	20 minutes
Secondary	Plantar pressure distribution	Baropodometry	20 minutes